February 18, 2021 01:42 PM EST

Endpoints Manufacturing: 5 Questions with Homology Medicines

Conner Mitchell

This week, I asked five questions of Tim Kelly, the chief technology officer at Homology Medicines. Kelly has over two decades of experience in manufacturing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Endpoints Manufacturing: 5 Questions with Homology Medicines

Conner Mitchell

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

CBER's deputy director departs as staff shakeup continues

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

FDA approves first drug to treat ultra-rare lipid storage disease

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

FDA says Ozempic, Wegovy shortage is over

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

End­points Man­u­fac­tur­ing: 5 Ques­tions with Ho­mol­o­gy Med­i­cines

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Endpoints Manufacturing: 5 Questions with Homology Medicines